Education
About Us
Working with TipRanks
Follow Us
Lexington Biosciences Inc (LXGTF)
OTHER OTC:LXGTF
Total Valuation
Lexington Biosciences has a market cap or net worth of $221.44K. The enterprise value is ―.
Market Cap$221.44K
Enterprise Value―
Share Statistics
Lexington Biosciences has 3,786,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,786,840
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lexington Biosciences’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 15.96%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)15.96%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lexington Biosciences is ―. Lexington Biosciences’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value>-0.01
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Lexington Biosciences had revenue of 0.00 and earned -177.38K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-158.00K
Pretax Income-177.00K
Net Income-177.38K
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Lexington Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.60
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Lexington Biosciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Lexington Biosciences as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Lexington Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lexington Biosciences EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Lexington Biosciences has $0.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $0.00 billion.
Cash & Marketable Securities$0.00
Total Debt$0.00
Net Cash$0.00
Net Cash Per Share$0.00
Tangible Book Value Per Share-$0.06
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Lexington Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―